Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2005
03/16/2005CN1596254A Process for the prereparation of compositions having an increased amount of pharmaceutically active salts of rotamers
03/16/2005CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents
03/16/2005CN1596251A Piperazine derivatives having SST1 antagonistic activity
03/16/2005CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them
03/16/2005CN1596247A Lactam derivatives as antagonists for human 11CBY receptors
03/16/2005CN1596246A Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
03/16/2005CN1596141A Conjugated anti-psychotic drugs and uses thereof
03/16/2005CN1596130A Genetic remedies for neurodegenerative diseases
03/16/2005CN1596128A Pharmaceutical compositions of 5, 7, 14-triazatetracyclo[10.3.1.0(2, 11).0(4, 9)]-hexadeca-2(11)3, 5, 7, 9-pentaene
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer
03/16/2005CN1596113A Method of treating depression with delta receptor agonist compounds
03/16/2005CN1596112A Benzothiazole derivatives
03/16/2005CN1596110A Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells
03/16/2005CN1594277A Method for preparing memantine hydrochloride
03/16/2005CN1593639A Chinese medicine decoction for treating flaccidity syndrome
03/16/2005CN1593634A Blood nourishing, brain refreshing orally disintegrating tablet and its preparation process
03/16/2005CN1593566A Hemiplegia treating pill
03/16/2005CN1593556A Brain tonifying capsule
03/16/2005CN1593553A Refreshing and brain tonifying powder
03/16/2005CN1593486A Pharmaceutical composition for stopping drug addiction and its preparing process
03/16/2005CN1593482A Medicine for treating hypomnesis of middle aged and old man and its preparation process
03/16/2005CN1593481A Chinese patent medicine for treating neurasthenia
03/16/2005CN1593473A Application of a pharmaceutical composition in the preparing process of medicine for treating chronic alcohol intake caused injury
03/16/2005CN1593467A Method for extracting medicinal and edible substance from dictyoptera
03/16/2005CN1593420A Ginkoleaf extract and diphyridamole powder injection and its preparation
03/16/2005CN1593412A Method for preparing nimodipine carrying float sustained release mini capsule
03/16/2005CN1593399A Application of compound laetispicine in the process for preparing pharmaceutical composition
03/16/2005CN1593395A Sobering agent prepared by acetyl cysteine
03/16/2005CN1593391A Application of biphenyl cyclooctene containing substance in the process for preparing Alzheimer disease treating medicine
03/16/2005CN1593389A Cool plaster and its processing method and usage
03/16/2005CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same
03/16/2005CN1193019C Method and reagents for N-alkylating ureides
03/16/2005CN1192799C Adjuvant combination formulations
03/16/2005CN1192797C Combination vaccine against streptocouus pneumoniae and respiratory syncytial virus (RSV)
03/16/2005CN1192777C Use of a indolequinoxaline compound for preparing multiple sclerosis a drug
03/16/2005CN1192767C Capsule and binding agent for pharmaceutical formulations with improved storage stability
03/16/2005CA2480218A1 New derivatives of benzoindoline, preparation thereof, and pharmaceutical compounds containing them
03/15/2005US6867236 Method of preventing of delaying the onset and progression of Alzheimer's disease and related disorders
03/15/2005US6867226 Preventing diarrhea
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867220 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them
03/15/2005US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release
03/15/2005US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/15/2005US6867204 Benzoxazine derivatives and uses thereof
03/15/2005US6867202 Treatment of insulin resistance
03/15/2005US6866851 GFRα1-RET specific agonists and methods therefor
03/15/2005CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists
03/15/2005CA2255659C Neuroactive peptides
03/15/2005CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/15/2005CA2085785C The use of 4-aminopyridine in the treatment of a neurological condition
03/10/2005WO2005021555A1 Bicyclic piperazine compound and use thereof
03/10/2005WO2005021545A1 IMIDAZO[1,5-a]PYRIDINE OR IMIDAZO[1,5-a]PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS
03/10/2005WO2005021534A1 1,3-dihydro-2h-indol-2-one derivative
03/10/2005WO2005021525A1 Aryl piperidine amides
03/10/2005WO2005021513A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases
03/10/2005WO2005021505A1 The claimed invention relates to novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-ht2a receptor-related disorders
03/10/2005WO2005021095A2 Treatment of stuttering and other communication disorders with norepinephrine reuptake inhibitors
03/10/2005WO2005021024A1 Amino acid derived prodrugs of propofol, compositions and uses thereof
03/10/2005WO2005021021A1 Extract of nelumbinis semen for the treatment of depression
03/10/2005WO2005021005A2 Process for the preparation of 1,4-benzodiazepine derivatives
03/10/2005WO2005021003A2 Immunosuppressive effects of pteridine derivatives
03/10/2005WO2005020992A1 Novel medical use of selective cb1-receptor antagonists
03/10/2005WO2005020988A1 Use of 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
03/10/2005WO2005020982A2 Using selective antagonists of persistent sodium current to treat neurological disorders and pain
03/10/2005WO2005020976A2 Treatment of pervasive developmental disorders with norepinephrine reuptake inhibitors
03/10/2005WO2005020975A2 Treatment of learning disabilities and motor skills disorder with norepinephrine reuptake inhibitors
03/10/2005WO2005020974A1 Novel use of a polyamine-poor composition for the production of a medical human food
03/10/2005WO2005020904A2 Oral neurotherapeutic cefazolin compositions
03/10/2005WO2005003288A3 Diagnostic methods , prognostic methods and pharmaceutical compositions for neurodegenerative diseases like alzheimer’s disease by modulating and investigating genes rgs4 and itpkb, their gene products or fragments and derivatives thereof
03/10/2005WO2004112806A8 Composition for treating or preventing neural disorders
03/10/2005WO2004097320A8 Thermal energy storage
03/10/2005WO2004096225A3 Use of tyrosine kinase inhibitors for treating cerebral ischemia
03/10/2005WO2004041802A8 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
03/10/2005WO2004041794A8 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
03/10/2005WO2003079987A3 A non-selective cation channel in neural cells and methods for treating brain swelling
03/10/2005WO2003073062A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
03/10/2005WO2003072046A3 Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
03/10/2005WO2003037167A9 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
03/10/2005WO2003027254A9 15625 receptor, a novel g-protein coupled receptor
03/10/2005WO2003007875A9 Compounds with analgesic, antipyretic and/or anti-inflammatory activity
03/10/2005WO2002087604A8 Preparations containing a combination of vitamin e and afamin
03/10/2005US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics
03/10/2005US20050054732 Preventives or remidies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
03/10/2005US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases
03/10/2005US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases
03/10/2005US20050054700 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
03/10/2005US20050054698 4-(4Methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3)
03/10/2005US20050054690 Phenacyl 2-hydroxy-3-diaminoalkanes
03/10/2005US20050054674 Activator of peroxisome proliferator-activated receptor
03/10/2005US20050054661 Irritable bowel disorders; anxiolytic agents; antidepressants
03/10/2005US20050054656 Therapy for obesity, eating disorders, psychological disorders, antidepressants, central nervous system disorders
03/10/2005US20050054653 Pteridine derivatives, method of producing them and their application
03/10/2005US20050054641 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/10/2005US20050054635 Therapy , prevention of obsessive-complusive disorders; antidepressants; anxiety; schizophrenia; eating disorders; obesity; antiepileptic agents central nervous system disorders; sleep disorders
03/10/2005US20050054624 Administering steroid9such as estrogen) containing hydrophobic substitution such as adamamtane ring; Alzheimer's, Parkinson's, Huntington's disease; multiple sclerosis; amyotropic lateral sclerosis; stroke; antiischemic agents
03/10/2005US20050054623 Transdermal supplying testosterone gel
03/10/2005US20050054605 Partial or full A1 agonists - N6 heterocyclic 5' thio substituted adenosine derivatives
1 ... 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 ... 1833